379 related articles for article (PubMed ID: 15196646)
1. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
2. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
3. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
Abberger T
Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
[TBL] [Abstract][Full Text] [Related]
4. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z
Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
8. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
[TBL] [Abstract][Full Text] [Related]
9. Frosta: a new technology for making fast-melting tablets.
Jeong SH; Fu Y; Park K
Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
[TBL] [Abstract][Full Text] [Related]
10. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
Pabari RM; Ramtoola Z
Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
[TBL] [Abstract][Full Text] [Related]
11. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
13. Formulation design of a novel fast-disintegrating tablet.
Mizumoto T; Masuda Y; Yamamoto T; Yonemochi E; Terada K
Int J Pharm; 2005 Dec; 306(1-2):83-90. PubMed ID: 16257154
[TBL] [Abstract][Full Text] [Related]
14. Twin screw granulation as a simple and efficient tool for continuous wet granulation.
Keleb EI; Vermeire A; Vervaet C; Remon JP
Int J Pharm; 2004 Apr; 273(1-2):183-94. PubMed ID: 15010142
[TBL] [Abstract][Full Text] [Related]
15. Fast-melting tablets based on highly plastic granules.
Fu Y; Jeong SH; Park K
J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
[TBL] [Abstract][Full Text] [Related]
16. The influence of binder type and concentration on the physical characteristics of calcium carbonate granules and their corresponding tablets.
Elsabbagh HM; Ghanem AH; Abdel-Alim HM
Pharmazie; 1981 Aug; 36(8):548-51. PubMed ID: 7291287
[TBL] [Abstract][Full Text] [Related]
17. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
[TBL] [Abstract][Full Text] [Related]
18. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
Kuno Y; Kojima M; Ando S; Nakagami H
J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of dried yeast tablets using different techniques.
Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
